Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS

Phase 2

Conditions: Non-Small Cell Lung Cancer With EGFR T790M Mutation
Failed Tyrosine Kinase Inhibitors
With Brain and/or Leptomeningeal Metastasis

Interventions: Drug: AZD9291

First Posted Date: 2017-08-22

Last Posted Date: 2021-08-16

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 80

Registration Number: NCT03257124

Locations: 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cm

Phase 2

Conditions: Lung Adenocarcinoma, Stage I

Interventions: Drug: Pembrolizumab

First Posted Date: 2017-08-18

Last Posted Date: 2020-12-14

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 70

Registration Number: NCT03254004

Locations: 🇰🇷
Samsung medical centre, Seoul, Kangnam, Korea, Republic of

Ultrasound-guided Block for Thoracic Surgery Pain

Not Applicable

Completed

Conditions: Thoracic Cancer
Postoperative Pain

Interventions: Drug: patient controlled analgesia
Procedure: serratus anterior plane block

First Posted Date: 2017-08-07

Last Posted Date: 2018-02-28

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 89

Registration Number: NCT03240562

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer

Phase 3

Active, not recruiting

Conditions: Prostate Neoplasm

Interventions: Radiation: Intensity modulated radiotherapy

First Posted Date: 2017-08-07

Last Posted Date: 2023-11-27

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 61

Registration Number: NCT03241537

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer

Not Applicable

Completed

Conditions: Cervix Cancer
Radiotherapy, Adjuvant
Radiotherapy, Intensity-Modulated
Chemotherapy, Concurrent
Hypofractionated Dose

Interventions: Other: POHIM-CCRT

First Posted Date: 2017-08-04

Last Posted Date: 2025-01-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 84

Registration Number: NCT03239613

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Not Applicable

Active, not recruiting

Conditions: Hypofractionated Dose
Cervix Cancer
Radiotherapy, Intensity-Modulated
Radiotherapy, Adjuvant

Interventions: Radiation: POHIM-RT

First Posted Date: 2017-08-04

Last Posted Date: 2025-03-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 120

Registration Number: NCT03239626

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Impact of Perioperative Physical Activity on Postoperative Pulmonary Complications and Quality of Life Among Esophageal Cancer Patients

Recruiting

Conditions: Esophageal Neoplasms

First Posted Date: 2017-07-27

Last Posted Date: 2018-10-11

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 180

Registration Number: NCT03231462

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor

Phase 2

Conditions: Thymic Cancer

Interventions: Drug: Palbociclib

First Posted Date: 2017-07-17

Last Posted Date: 2017-08-02

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 33

Registration Number: NCT03219554

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Development of Patient Tailored Guideline of Physical Activity for Lung Cancer

Not Applicable

Conditions: Lung Cancer

Interventions: Behavioral: comprehensive intervention

First Posted Date: 2017-07-12

Last Posted Date: 2021-03-17

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 176

Registration Number: NCT03215537

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Comparison Between Novel Flower-type Covered Stent and Conventional Covered Stent

Not Applicable

Conditions: Malignant Biliary Obstruction

Interventions: Device: Endoscopic Retrograde CholangioPancreatography(ERCP)

First Posted Date: 2017-07-12

Last Posted Date: 2017-07-12

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 256

Registration Number: NCT03215108

Locations: 🇰🇷
SamsungMC, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy